Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIOCH-14 in Healthy Volunteers
NCT05976100Phase 1Completed
- Start
- Sep 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of NIOCH-14 in smallpox, mpox, cowpox and 1 more (6 arms). Primary endpoints: Hematology Parameters, Biochemistry Parameters and 4 more. Started Sep 2020; status: completed.
02
Drugs
NIOCH-14
03
Conditions
smallpoxmpoxcowpoxvaccinia virus infection
Beyond the preview
Go deeper on NCT05976100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05976100.